CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 65 filers reported holding CASI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $9,489,000 | 30.38% |
| Consonance Capital Management LP | 1,563,003 | $1,860,000 | 1.02% |
| Wellington Shields & Co., LLC | 1,832,769 | $2,181,000 | 0.76% |
| Wellington Shields Capital Management, LLC | 2,258,265 | $2,687,000 | 0.37% |
| Ghost Tree Capital, LLC | 650,000 | $774,000 | 0.23% |
| Ikarian Capital, LLC | 1,223,067 | $1,456,000 | 0.10% |
| 1492 Capital Management LLC | 78,762 | $94,000 | 0.05% |
| Sterneck Capital Management, LLC | 40,000 | $48,000 | 0.03% |
| FEDERATED HERMES, INC. | 10,150,000 | $12,079,000 | 0.02% |
| XTX Topco Ltd | 41,324 | $49,000 | 0.02% |